NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

雙極性憂鬱症:流行病學預測(2030年)

Bipolar Depression - Epidemiology Forecast - 2030

出版商 DelveInsight Business Research LLP 商品編碼 952552
出版日期 按訂單生產 內容資訊 英文 100 Pages
商品交期: 10個工作天內
價格
雙極性憂鬱症:流行病學預測(2030年) Bipolar Depression - Epidemiology Forecast - 2030
出版日期: 按訂單生產內容資訊: 英文 100 Pages
簡介

主要7個國家在(美國、德國、法國、義大利、西班牙、英國、日本)中診斷出雙極性憂鬱症的病患人口的總合,2017年為185萬7,545人。美國估計740,715件,盛行率成為最高比例。歐洲的5個國家中,法國的病患人口最多成為27萬8,145件,其次是德國和英國。另一方面,在西班牙是8萬9,599件最少。還有日本為21萬902件。

本報告提供主要7個國家與(美國、德國、法國、義大利、西班牙、英國、日本)的雙極性憂鬱症的相關調查,疾病的背景和概要,流行病學另外的流行病學等資訊患者人口,主要7個國家。

目錄

第1章 主要洞察

第2章 摘要整理

第4章 疾病的背景和概要

  • 簡介
  • 各DSM-5躁鬱症的分類
  • 症狀
  • 原因
  • 危險因素
  • 病理生理學
  • 躁鬱症的遺傳學觀察
  • 生物標記
  • 診斷

第5章 流行病學和患者人口

  • 主要調查結果
  • KOL的檢討
  • 流行病學調查手法
  • 主要7個國家的診斷患病案例的總數

第6章 美國的流行病學

  • 前提條件與根據
  • 診斷患病案例的總數
  • 各類型診斷盛行率
  • 各重症度診斷盛行率

第7章 歐洲5個國家的流行病學

  • 德國流行病學
  • 法國流行病學
  • 義大利流行病學
  • 西班牙流行病學
  • 英國的流行病學

第8章 日本的流行病學

  • 前提條件與根據
  • 診斷患病案例的總數
  • 各類型診斷盛行率
  • 各重症度診斷盛行率

第9章 附錄

  • 參考文件
  • 報告調查手法

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI0046

DelveInsight's 'Bipolar Depression-Epidemiology Forecast-2030' report delivers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Bipolar Depression Disease Understanding

Bipolar disorder (BD), previously known as manic depressive illness or manic depression, is a mental disorder characterized by wide mood swings from high (manic) to low (depressed). In manic episodes, a person can be very happy, irritable, or "up", and there is a marked increase in activity level. Hypomanic episodes are also seen in patients and it is a less severe form of mania. In depressive episodes (bipolar depression), the patient might feel sad, indifferent, or hopeless, in combination with a very low activity level.

BD is divided mainly into four subtypes BD-I, BD-II, cyclothymic disorder, and bipolar disorder not otherwise specified (NOS). The classification is based on the characteristics of mood swings. The symptoms of BD can vary and individuals may have episodes of mania, depression, or mixed episodes. The depressive episodes usually last longer than mania and hypomania.

The symptoms of Bipolar Depression include feeling sad or anxious; restless; trouble concentrating or making decisions; trouble falling asleep, waking up too early, or sleeping too much; lack of interest; feeling hopeless or worthless, or thinking about death or suicide; unable to do even simple things, and talking very slowly, feeling like he/she has nothing to say, or forgetting a lot.

Bipolar Depression Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Prevalent Cases of Bipolar Depression, Type-specific Diagnosed Prevalent Cases of Bipolar Depression and Severity-specific Diagnosed Prevalent Cases of Bipolar Depression scenario of Bipolar Depression in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2017 to 2030.

Bipolar Depression Detailed Epidemiology Segmentation

  • As per DelveInsight analysts, the total diagnosed prevalent population of Bipolar Depression in the 7MM was 1,857,545 in 2017.
  • The estimates show the highest diagnosed prevalence of Bipolar Depression in the United States with 740,715 cases.
  • Bipolar I and Bipolar II are the major subtypes of BD. In 2017, out of the total diagnosed prevalent population of 740,715 cases in the US for Bipolar Depression, 291,134 and 449,581 cases were contributed by Bipolar I disorder and Bipolar II disorder, respectively.
  • Based on the severity of the Bipolar Depression, total diagnosed prevalent cases are categorized into mild, moderate and severe. In 2017, out of the total diagnosed prevalent population in the US for Bipolar Depression, 28,666 cases were mild, 158,735 cases were moderate, and 553,092 cases were severe.
  • Among the European five countries, France had the highest diagnosed population of Bipolar Depression with 278,145 cases, followed by Germany and the UK. On the other hand, Spain had the lowest diagnosed prevalent population of 89,599 cases in 2017.
  • Total diagnosed prevalent cases of Bipolar Depression in Japan were found to be 210,902 in 2017.

Scope of the Report:

  • The report covers the descriptive overview of Bipolar Depression, explaining its causes, symptoms, pathophysiology, and genetic basis.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Bipolar Depression.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Diagnosed Prevalent Cases of Bipolar Depression, Type-specific Diagnosed Prevalent Cases of Bipolar Depression and Severity-specific Diagnosed Prevalent Cases of Bipolar Depression.

Report Highlights:

  • 11-Year Forecast of Bipolar Depression
  • 7MM Coverage
  • Total Diagnosed Prevalent Cases of Bipolar Depression
  • Type-specific Diagnosed Prevalent Cases of Bipolar Depression
  • Severity-specific Diagnosed Prevalent Cases of Bipolar Depression

Key Questions Answered

  • What is the disease risk, burden and unmet needs of Bipolar Depression?
  • What is the historical Bipolar Depression patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
  • What would be the forecasted patient pool of Bipolar Depression at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Bipolar Depression?
  • Out of the above-mentioned countries, which country would have the highest prevalent population of Bipolar Depression during the forecast period (2020-2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2020-2030)?

Reasons to buy:

The Bipolar Depression report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the 7MM Bipolar Depression epidemiology forecast.
  • The Bipolar Depression epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Bipolar Depression epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030.

Table of Contents

1. Key Insights

2. Executive Summary of Bipolar Depression

4. Disease Background and Overview: Bipolar Depression

  • 4.1. Introduction
  • 4.2. Classification of Bipolar Disorder According to DSM-5
  • 4.3. Symptoms
  • 4.4. Causes
  • 4.5. Risk Factors
  • 4.6. Pathophysiology
  • 4.7. Genetics Findings in Bipolar Disorder
  • 4.8. Biomarkers
  • 4.9. Diagnosis

4.9.1.Diagnostic Guidelines

5. Epidemiology and Patient Population

  • 5.1. Key Findings
  • 5.2. KOL Views
  • 5.3. Epidemiology Methodology
  • 5.4. Total Diagnosed Prevalent Cases of Bipolar Depression in the 7MM

6. United States Epidemiology

  • 6.1. Assumptions and Rationale
  • 6.2. Total Diagnosed Prevalent Cases of Bipolar Depression in the United States
  • 6.3. Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the United States
  • 6.4. Severity-specific Diagnosed Prevalent cases of Bipolar Depression in the United States

7. EU5 Epidemiology

  • 7.1. Germany Epidemiology

7.1.1.Assumptions and Rationale

7.1.2.Total Diagnosed Prevalent Cases of Bipolar Depression in Germany

7.1.3.Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany

7.1.4.Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany

  • 7.2. France Epidemiology

7.2.1.Assumptions and Rationale

7.2.2.Total Diagnosed Prevalent Cases of Bipolar Depression in France

7.2.3.Type-specific Diagnosed Prevalent Cases of Bipolar Depression in France

7.2.4.Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in France

  • 7.3. Italy Epidemiology

7.3.1.Assumptions and Rationale

7.3.2.Total Diagnosed Prevalent Cases of Bipolar Depression in Italy

7.3.3.Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy

7.3.4.Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy

  • 7.4. Spain Epidemiology

7.4.1.Assumptions and Rationale

7.4.2.Total Diagnosed Prevalent Cases of Bipolar Depression in Spain

7.4.3.Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain

7.4.4.Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain

  • 7.5. United Kingdom Epidemiology

7.5.1.Assumptions and Rationale

7.5.2.Total Diagnosed Prevalent Cases of Bipolar Depression in the UK

7.5.3.Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK

7.5.4.Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK

8. Japan Epidemiology

  • 8.1. Assumptions and Rationale
  • 8.2. Total Diagnosed Prevalent Cases of Bipolar Depression in Japan
  • 8.3. Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Japan
  • 8.4. Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Japan

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

List of Tables

  • Table 1 Summary of Bipolar Depression, Epidemiology and Key Events (2017-2030)
  • Table 2 Symptoms associated with manic and depressive episodes
  • Table 3 GWAS findings in bipolar disorder
  • Table 4 Main findings of circulating biomarkers in bipolar disorder
  • Table 5 Total Diagnosed Prevalent Cases of Bipolar Depression in the 7MM (2017-2030)
  • Table 6 Total Diagnosed Prevalent Cases of Bipolar Depression in the United States (2017-2030)
  • Table 7 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the United States (2017-2030)
  • Table 8 Severity-specific Diagnosed Prevalent cases of Bipolar Depression in the US (2017-2030)
  • Table 9 Total Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Table 10 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Table 11 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Table 12 Total Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Table 13 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Table 14 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Table 15 Total Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Table 16 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Table 17 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Table 18 Total Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Table 19 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Table 20 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Table 21 Total Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Table 22 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Table 23 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Table 24 Total Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)
  • Table 25 Total Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)
  • Table 26 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)

List of Figures

  • Figure 1 Main subtypes of bipolar disorder
  • Figure 2 Symptoms of bipolar disorder
  • Figure 3 Effects of bipolar disorder on the body
  • Figure 4 Causes of bipolar disorder
  • Figure 5 Triggers in bipolar disorder
  • Figure 6 Multifactorial model of bipolar disorders
  • Figure 7 Symptoms with potential diagnostic utility in bipolar and unipolar depression
  • Figure 8 United States KOL Views
  • Figure 9 EU-5 and Japan KOL Views
  • Figure 10 Total Diagnosed Prevalent Cases of Bipolar Depression in the 7MM (2017-2030)
  • Figure 11 Total Diagnosed Prevalent Cases of Bipolar Depression in the United States (2017-2030)
  • Figure 12 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the United States (2017-2030)
  • Figure 13 Severity-specific Diagnosed Prevalent cases of Bipolar Depression in the US (2017-2030)
  • Figure 14 Total Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Figure 15 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Figure 16 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Germany (2017-2030)
  • Figure 17 Total Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Figure 18 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Figure 19 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in France (2017-2030)
  • Figure 20 Total Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Figure 21 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Figure 22 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Italy (2017-2030)
  • Figure 23 Total Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Figure 24 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Figure 25 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Spain (2017-2030)
  • Figure 26 Total Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Figure 27 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Figure 28 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in the UK (2017-2030)
  • Figure 29 Total Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)
  • Figure 30 Type-specific Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)
  • Figure 31 Severity-specific Diagnosed Prevalent Cases of Bipolar Depression in Japan (2017-2030)